Angiotensin Converting Enzyme Inhibitors Prescribing Pattern For Different Indications: A Population Based Study.

Conclusion: Although ACE-inhibitors are usually initiated for life long treatment, a high percentage of ACE-inhibitors starters will stop or switch their therapy. The highest risk of discontinuation or switching in renal disease patients and heart failure patients. Table 1. General characteristics of included patients stratified for different indications (N= 276,977patients). Introduction: Angiotensin converting enzyme inhibitors (ACE-inhibitors) are one of the most frequently prescribed groups of medications which are commonly used in the treatment of hypertension, heart failure, myocardial infarction and renal disease. A substantial number of patients discontinue therapy with ACE-inhibitors.